These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 31653936)
1. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort. Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936 [TBL] [Abstract][Full Text] [Related]
2. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751 [TBL] [Abstract][Full Text] [Related]
3. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356 [TBL] [Abstract][Full Text] [Related]
4. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias. van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835 [TBL] [Abstract][Full Text] [Related]
5. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis. van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111 [TBL] [Abstract][Full Text] [Related]
6. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis. Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827 [TBL] [Abstract][Full Text] [Related]
7. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349 [TBL] [Abstract][Full Text] [Related]
8. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis. Wu X; Li W; Luo Z; Chen Y Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291 [TBL] [Abstract][Full Text] [Related]
9. Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism. Cocconcelli E; Bernardinello N; Giraudo C; Castelli G; Greco C; Polverosi R; Saetta M; Spagnolo P; Balestro E Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555528 [TBL] [Abstract][Full Text] [Related]
10. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment. Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872 [TBL] [Abstract][Full Text] [Related]
11. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism. Chung JH; Peljto AL; Chawla A; Talbert JL; McKean DF; Rho BH; Fingerlin TE; Schwarz MI; Schwartz DA; Lynch DA Chest; 2016 May; 149(5):1215-22. PubMed ID: 26836909 [TBL] [Abstract][Full Text] [Related]
12. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis. Okamoto T; Mathai SK; Hennessy CE; Hancock LA; Walts AD; Stefanski AL; Brown KK; Lynch DA; Cosgrove GP; Groshong SD; Cool CD; Schwarz MI; Banda NK; Thurman JM; Yang IV; Holers VM; Schwartz DA Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L1-L10. PubMed ID: 29565179 [TBL] [Abstract][Full Text] [Related]
13. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. Wei R; Li C; Zhang M; Jones-Hall YL; Myers JL; Noth I; Liu W Transl Res; 2014 May; 163(5):494-502. PubMed ID: 24434656 [TBL] [Abstract][Full Text] [Related]
14. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF. Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995 [TBL] [Abstract][Full Text] [Related]
15. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations. Zhu QQ; Zhang XL; Zhang SM; Tang SW; Min HY; Yi L; Xu B; Song Y Medicine (Baltimore); 2015 Oct; 94(43):e1901. PubMed ID: 26512610 [TBL] [Abstract][Full Text] [Related]
16. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455 [TBL] [Abstract][Full Text] [Related]
17. The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries. Peljto AL; Selman M; Kim DS; Murphy E; Tucker L; Pardo A; Lee JS; Ji W; Schwarz MI; Yang IV; Schwartz DA; Fingerlin TE Chest; 2015 Feb; 147(2):460-464. PubMed ID: 25275363 [TBL] [Abstract][Full Text] [Related]
18. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis. Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633 [TBL] [Abstract][Full Text] [Related]